Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ikena Oncology Inc (IKNA)

Ikena Oncology Inc (IKNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ikena Oncology Inc 645 SUMMER STREET SUITE 101 BOSTON MA 02210 USA

www.ikenaoncology.com P: 857-273-8343

Description:

Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.

Key Statistics

Overview:

Market Capitalization, $K 62,253
Enterprise Value, $K -57,637
Shares Outstanding, K 48,258
Annual Sales, $ 9,160 K
Annual Net Income, $ -68,170 K
Last Quarter Sales, $ 660 K
Last Quarter Net Income, $ -19,490 K
EBIT, $ -75,420 K
EBITDA, $ -76,420 K
60-Month Beta 0.33
% of Insider Shareholders 5.95%
% of Institutional Shareholders 75.00%
Float, K 45,387
% Float 94.05%
Short Volume Ratio 0.49

Growth:

1-Year Return -73.94%
3-Year Return -94.73%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 03/12/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.64
EPS Growth vs. Prev Qtr -2.50%
EPS Growth vs. Prev Year -5.13%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IKNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.20%
Return-on-Assets % -37.27%
Profit Margin % -744.21%
Debt/Equity 0.00
Price/Sales 7.11
Price/Cash Flow N/A
Price/Book 0.38
Book Value/Share 3.52
Interest Coverage -1.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar